The phosphorylation of ZIP7 at these positions results in zinc release from intracellular stores, inhibiting protein tyrosine phosphatases (PTP), causing sustained activation of EGFR and Src [110] as well as ERK1/2 and AKT, which regulate signaling pathways leading to cancer cell proliferation and migration [111,112]. The gene discussed is SLC39A7; the disease is cancer.